Monday, 7 July 2014

Cipla plans to invest up to £100 mn in UK subsidiary

The investment underscores the growing importance of UK in Cipla’s long term strategy.

Cipla Ltd has announced that the Company, in collaboration with the UK government, has expressed its intention to make investments of up to £100 million in its UK subsidiary over the next few years.
The investments are expected to facilitate the launch of a range of products in the area of respiratory, oncology and antiretroviral medicines to further Cipla’s higher purpose of "universal affordable access". Cipla also plans to invest in R&D activities, clinical trials and expand further internationally.
The investment underscores the growing importance of UK in Cipla’s long term strategy.

No comments:

Post a Comment